Psychotropic Risks in Children and Adolescents (May/June)

Date of Issue: 05/01/2018 | Volume: 9 | Number: 4

Issue Links:Learning Objectives | Editorial Information

This issue covers the advantages and disadvantages of using psychotropic medications to treat children and adolescents. It also provides clinicians with the latest information on using metformin to minimize antipsychotic-induced weight gain. The benefits of following the informed consent process as it applies to youth patients and their families is also discussed.

In This Issue

Article

Informed Consent: An Ongoing Process for Focused Care

Topics: Child Psychiatry | Free Articles | Practice Tools and Tips

Informed consent is a foundation for good clinical practice and can provide legal protection. But informed consent is more than defensive medicine. It is a vehicle for framing good care. How often do people use the consent process?

Read More
Article

Embracing Conflict in the Consent Process

Topics: Child Psychiatry | Practice Tools and Tips

What do you do when your teen patient declines an offer of medication yet the parents insist on it? How about if the teen is coming to you for medication and the parents are opposed to the idea?

Read More
Expert Q&A

Considerations When Prescribing Psychotropic Medications

Topics: Child Psychiatry | Pharmacology Tips

How do you approach using psychotropic medications for children and adolescents? Most parents do not want to start medications. I empathize with them, which then makes it possible to move together toward medications when indicated.

Read More
Article

Metformin to Control Antipsychotic-Induced Weight Gain in Children

Topics: Antipsychotics | Child Psychiatry | Pharmacology Tips

Metformin has been used off-label for weight loss in psychiatry for many years, much of it for help with adult weight gain as a side effect of atypical antipsychotics. However, most trials of metformin for weight loss were actually conducted on the child and adolescent population. This article will look at the quality of the data in our pediatric population of 3 studies, and then come up with some recommendations for your practice.

Read More
Article

Tips for Good Medication Practice

Topics: Child Psychiatry | Pharmacology Tips

Good practice using psychotropic medications with children and adolescents requires a psychiatrist to pay attention to a number of elements.

Read More
Research Update

Youth, Antidepressant Medications, and Type 2 Diabetes

Topics: Antidepressants | Child Psychiatry | Psychopharmacology Tips

Over the last decade, several published studies have reported an increased risk of type 2 diabetes associated with antidepressant use in adults. But does the same hold true for children and adolescents?

Read More
CME Post-Test

CME Post-Test - Psychotropic Risks in Children and Adolescents, CCPR, May/June 2018

Topics: CME Post-Test

The post-test for this issue is available for one year after the publication date to subscribers. By successfully completing the test you will be awarded a certificate for 2 CME credits.

Read More